NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Upda

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 71,500 shares, a growth of 108.5% from the June 15th total of 34,300 shares. Based on an average trading volume of 72,200 shares, […]

Related Keywords

Canada , Manhattan , New York , United States , , Worth Venture Partners , Renaissance Technologies , Royal Bank , First Manhattan Co , Neubase Therapeutics Inc , Nasdaq , Neubase Therapeutics Company Profile , Neubase Therapeutics , Get Free Report , Street Corp , Venture Partners , Base Therapeutics , Neubase Therapeutics Daily , Nasdaq Nbse , Tnbse , Medical , Stocks , Options , Put , Call ,